Development of Neuropathy in Patients With Myeloma Treated With Thalidomide: Patterns of Occurrence and the Role of Electrophysiologic Monitoring
Mileshkin et al.
JCO 2006;24:4507-4514.
ABSTRACT
| FULL TEXT
Effects of Thalidomide on Developmental, Peri- and Postnatal Function in Female New Zealand White Rabbits and Offspring
Teo et al.
Toxicol Sci 2004;81:379-389.
ABSTRACT
| FULL TEXT
Thalidomide Treatment for Prurigo Nodularis in Human Immunodeficiency Virus-Infected Subjects: Efficacy and Risk of Neuropathy
Maurer et al.
Arch Dermatol 2004;140:845-849.
ABSTRACT
| FULL TEXT
Dermatologic and Nondermatologic Uses of Thalidomide
Nasca et al.
The Annals of Pharmacotherapy 2003;37:1307-1320.
ABSTRACT
| FULL TEXT
Thalidomide-induced neuropathy: A ganglionopathy?
Giannini et al.
Neurology 2003;60:877-878.
FULL TEXT
Low-Dose Thalidomide Therapy for Refractory Cutaneous Lesions of Lupus Erythematosus
Housman et al.
Arch Dermatol 2003;139:50-54.
ABSTRACT
| FULL TEXT
Lack of peripheral neuropathy in Beagle dogs after 53 weeks oral administration of thalidomide capsules
Teo et al.
Hum Exp Toxicol 2000;19:615-622.
ABSTRACT
Thalidomide for Aphthous Ulcers in HIV Infection
Birnkrant et al.
NEJM 1997;337:1086-1087.
FULL TEXT
Crossover Study of Thalidomide vs Placebo in Jessner's Lymphocytic Infiltration of the Skin
Guillaume et al.
Arch Dermatol 1995;131:1032-1035.
ABSTRACT
Thalidomide Neuropathy Incidence and Clinicoelectrophysiologic Findings in 42 Patients
Ochonisky et al.
Arch Dermatol 1994;130:66-69.
ABSTRACT
Successful Treatment of Adult's Langerhans Cell Histiocytosis With Thalidomide: Report of Two Cases and Literature Review
Thomas et al.
Arch Dermatol 1993;129:1261-1264.
ABSTRACT
Crossover Study of Thalidomide vs Placebo in Severe Recurrent Aphthous Stomatitis
Revuz et al.
Arch Dermatol 1990;126:923-927.
ABSTRACT